Adverse drug reactions [ADRs] are more frequently encountered in the elderly (> 60 years) population. The etiology is multifactorial and often interconnected with interplay of many factors like polypharmacy, altered drug pharmacokinetic and pharmacodynamics responses, drug interactions that increase their risk for ADR, making them a vulnerable population. Hence, the present study was taken up.
INTRODUCTION
ADRs are one of the leading causes of morbidity and mortality in health care. They are the fourth largest cause of death ahead of pulmonary disease, diabetes, AIDS, pneumonia. The elderly people appear to be particularly at risk of experiencing an ADR due to the interplay of range of factors like polypharmacy, altered drug pharmacokinetic profiles and pharmacodynamics responses, drug interactions and cognitive problems that increase the risk in this group 1 According to the World Health Organization (WHO), world's elderly population i.e., people 60 years of age and older is approximately 650 million at present and by 2050, it is forecast to reach 2 billion with 80% of them living in developing countries2
Many epidemiological studies have reported high prevalence rate i.e 24% hospital admissions are due to ADRs in elderly as compared to 3 to 6% in other age groups. These ADRs increase the economic burden and contribute to excessive health care costs through increased patient morbidity and mortality. They contribute up to 5 to 10% of hospital costs 3 The US FDA states that an estimate of the cost of drug-related morbidity and mortality is $136 billion annually, which is more than the total cost of cardiovascular or diabetic care in the United States. The Indian scenario as reported by a study show that total cost of hospital stay due to ADRs is estimated to be US $4350 that is US $80.5 per patient (108.7% of per capita per year expenditure on health) 4 Many studies on the reporting of ADRs are available. However an emphasis on identifying ADRs and related problems in elderly in India is limited which continues to face an increase in elderly population and chronic conditions. Hence the present study aims to evaluate the clinical pattern, causality, severity & preventability of ADRs, potentially inappropriate medicines causing ADRs among elderly population in our teaching hospital.
MATERIALS AND METHODS
It is a prospective observational study carried out in Bangalore Medical College and Research Centre, Bangalore. After obtaining approval from the ethics committee all the ADRs reported from patients e"60 years from various departments of Victoria hospital attached to Bangalore medical college and research institute were collected from June 2011 to December 2015.
Relevant data on patient's demographics, causal drug details, dosage, duration of therapy, route of drug administration, details of ADR's like date of occurrence of events, brief description of the reaction, duration of reaction, treatment given with relevant investigation reports were collected as per CDSCO ADR reporting form.
Adverse drug reaction was defined as an effect that is noxious and unintended, and which occurs at doses used in man for prophylaxis, diagnosis and therapy as per WHO guidelines. We followed the United Nations agreed cutoff e"60 years to refer to the older population/elderly 5 International Classification of Disease (ICD-10)11 was used for coding the diagnosis and Anatomical Therapeutic Chemical (ATC) 12 classifications was used for medications.
Causality and severity assessment: The causality was assessed by using WHO causality assessment scale and severity was assessed by using the Hartwig severity assessment scale according to the recommendation by the WHO Uppsala Monitoring Center.
ADRs were assessed for preventability using modified Thornton and Schumock scale. Potentially inappropriate medicines (PIM) were determined according to Beer's criteria.
RESULTS
During the study period, a total of 809 ADRs were collected from the various department of Victoria hospital attached to Bangalore medical college and research institute. Out of the total, 89 ADRs were reported from the elderly age group which constitutes for 11% of the total ADRs. [ Figure  1 ]
The gender distribution among the patients, who experienced ADRs were 56 (62.9%) males and 33 (37.1%) females [ Figure 2 ]. Similarly, among total ADRs reported, 77 (86.51%) patients were 60-70 years, 11 (12.35%) were 71-80 years and 1(1.12%) patient was more than 80 years.
Distribution of ADRs across therapeutic classes was as follows: Antimicrobials (22.5%) J01cephalosporins, Analgesics (20.22%) N02 NSAID's, Anti-hypertensives (7.86%), Antivirals J05 (6.7%) [ Figure 3 ] Among the individual drugs, Ceftriaxone was associated with maximum cases of ADRs (15.73%) followed by Diclofenac (11.23%) The frequency of ADRs associated with different routes of administration was as follows: Oral (n 48), parenteral (n 29), and topical (n 12).
The dermatological side effects (e.g. papular rash, itching etc.) were at the top with 34.83% followed by gastrointestinal disorders (29.21%) and neurological disorders (12.35%). The detailed description of organ systems affected by ADRs is shown in Table 2 .
Out of the 89 ADRs, 46 (51.68%) were found to be mild, 35 (39.32%) moderate and 8 (8.98%) severe. [ Figure 4 ] Most of the severe ADRs were associated with anti-tubercular and antiretroviral drugs.
In 66.29% of cases the drug was withdrawn, dose unchanged (28%), dose reduced (5.6%). 74% of the patients recovered symptomatically of the ADRs while 26% were in recovering stage.
Causality assessment revealed that 78 ADRs (87.6%) belonged to "probable" category, whereas 11 (12.40%) were of "possible" type according to the WHO-UMC scale. No case could be labeled "certain", as re-challenge was not attempted by the health care professional, once a drug was withdrawn [ Figure 5 ]. Majority were type A (98.87%) ADRs and probably preventable (92.1%). 
DISCUSSION
The prevalence of disease increases with age and elderly are frequent medication users.
Increased sensitivity to drug effects among the elderly results from changes in pharmacokinetics and pharmacodynamics. Age related losses of physiologic function also may predispose the older patient to adverse drug reactions.
Recognizing ADRs elderly becomes highly important since only around 3000 subjects receive a medicine prior to marketing, and often many (particularly type B) ADRs are often recognized only after marketing. These premarketing studies include only limited numbers of patients in the age group of 65 or older in trials and that even smaller numbers of the oldest old. In addition, long latency diseases like cancer are difficult to detect on account of the short duration of study.
In our study, we found that, there was a male preponderance 56 (62.92%). This is correlated with a study conducted by Veena et al. in Bengaluru In the study majority of the ADRs were caused by antimicrobials cephalosporins followed by NSAIDs. This is in contrast with another study conducted by Mandavi et al who reported calcium channel blockers, ACE inhibitors as the major causative drugs for ADRs in elderly.
In our study among the antimicrobials cephalosporin's and fluoroquinolones was the most common antibiotic class affecting the skin and GIT system used in the inpatient setting. These drugs caused generalized maculopapular rashes. A study conducted by Stavreva et al. also revealed the predominance of cephalosporins whereas fluoroquinolones were most accounted in a study conducted by Hussain et al 8, 9 A study of antibiotic dosage errors involving 1044 hospitalized patients >80 years of age revealed an overall rate of dosing error of 34% 10 . Third-generation cephalosporins and gentamicin were most commonly associated with dosing errors among the antibiotics studied, with error rates of 50% and 65%, respectively. Antimicrobials are frequently used to treat most common infections seen in elderly like pneumonia, urinary tract infections. An insufficient adjustment to the dosage for patients with renal dysfunction remains a significant contributor to antimicrobial-induced adverse events. These drugs should be initiated only when there is a clear potential clinical benefit and discourage irrational use that promote resistance. Empirical broadspectrum antibiotics should be narrowed when a pathogen is identified.
Our study reported NSAIDs as the second most offending agents causing ADRs in elderly. Multiple studies support the finding of an increased risk of GI-related adverse drug events due to NSAIDs (11) which was also observed in our study. Most of these agents are extensively hepatically metabolized by Phase I cytochrome P450 iso enzymes 12, 13, 14 Most NSAIDs are well-absorbed and highly plasma protein bound. Therefore, frail elders with hypoalbuminemia are likely to have higher free drug concentrations. Some agents have longer half-lives in older adults when compared to those determined in younger adults (i.e., celecoxib). Antiretrovirals, like most chronically administered drugs, are reported to have adverse reaction. Zidovudine (ZDV) is the preferred nucleoside reverse transcriptase inhibitor in the first line antiretroviral regimen in India. It is known to be associated with life threatening toxicity like anaemia. The prevalence of zidovudine induced anaemia vary widely (5.42-9.62%), in studies from different parts of the world. In our study we found that antiviral agents caused 6 ADRs out of which 4 were zidovudine induced anaemia. These can be managed by careful monitoring of hemoglobin levels, switch over to alternative drugs like tenoforvir or treatment with eptoein alpha. These antiviral agents were the causative drugs for serious ADRs encountered in our study to be followed by antitubercular drugs.
In this study the causal relation for 87.6 per cent ADRs with drug was probable; corroborating with other results showing majority of reactions as probable. (15) 17, 18 ADRs in elderly are largely contributed by prescribing error e.g., large doses of drugs without taking into account, the effect of age and frailty on drug disposition, especially renal and hepatic clearance. Increased pharmacodynamic sensitivity of the elderly to several commonly used drugs, e.g., central nervous system and cardiovascular drugs should also be considered while prescribing in elderly. Maintaining accurate record of all medications, monitoring to balance the need and avoiding polypharmacy, titrating from a small dose and individualizing dose to each patient, involving patient in decision of their therapy and educating them about the side effects of the drug are the strategies that can be employed by the physicians which will decrease the potential adverse drug reactions.
The present study is consistent in results with previous studies but the limitations were the lack of availability of information on polypharmacy and comorbidities due to incomplete documentation of data.
CONCLUSION
The present study attempted to study the pattern of ADRs and their distribution among different elderly age groups, organ systems affected, and therapeutic classes of medicines. Such studies conducted across multiple centers will serve as geriatric ADR database that can provide early warning signals of drug-reaction links if kept under active scrutiny.
The study reveals majority of the ADRs in elderly are predictable and preventable and are caused by commonly prescribed drugs like antimicrobials and analgesics. Nearly one fourth of the ADRs were due to PIM which can be minimized by careful application of Beer's criteria. Multiple methods with the aim of reducing the occurrence of ADR, including trying to identify at risk patients in order to target additional attention and intervention are necessary.
In addition to aims to promote understanding, education and clinical training in pharmacovigilance to various target groups, it is imperative that the information collected is effectively communicated back to the public to ensure pharmacovigilance delivers its full benefit.
